This review explore the rise of multidrug-resistant (MDR) Gram-negative bacteria, highlighting β-lactamase inhibitor combinations as crucial therapeutic options. It examines β-lactam resistance mechanisms, established combinations (e.g., ticarcillin/clavulan... ...

请注册登录后继续浏览